AngioLab Inc (251280)

Currency in KRW
4,080
-15(-0.37%)
Closed·
251280 Scorecard
Full Analysis
Suffers from weak gross profit margins
Unusual trading volume
251280 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4,0004,100
52 wk Range
3,7159,200
Key Statistics
Bid/Ask
4,045.00 / 4,070.00
Prev. Close
4,095
Open
4,100
Day's Range
4,000-4,100
52 wk Range
3,715-9,200
Volume
2.49K
Average Volume (3m)
913
1-Year Change
-44.79%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
251280 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a poor free cash flow yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

AngioLab Inc Company Profile

Angiolab, Inc., a biotechnology company, develops medicine with angiogenesis inhibitors for treating angiogenesis-related diseases. Its Phase I products consist of AL101-PSO for psoriasis. The company’s Phase II a clinical trial products include AL101- NASH for the treatment of non-alcoholic steatohepatitis; AL101-OME, for otitis media with effusion; and AL102-PDT for periodontitis. Its Phase II clinical trial products comprise AL101-AMD to treat age related muscular degeneration; and AL101-AOB for the treatment of abnormal obesity. In addition, the company provides ob-X for visceral fat reduction; and specific function and health functional food. Further, it offers AL201-AB, which is in the pre-clinical stage for the treatment of cancer, ocular diseases, etc. The company was founded in 1999 and is headquartered in Daejeon, South Korea.

Compare 251280 to Peers and Sector

Metrics to compare
251280
Peers
Sector
Relationship
P/E Ratio
0.0x−4.4x−0.5x
PEG Ratio
0.00−0.090.00
Price/Book
0.0x2.1x2.6x
Price / LTM Sales
0.0x19.7x3.3x
Upside (Analyst Target)
0.0%28.1%43.5%
Fair Value Upside
Unlock−2.2%6.8%Unlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

251280 Income Statement

FAQ

What Stock Exchange Does AngioLab Trade On?

AngioLab is listed and trades on the Korea New Exchange stock exchange.

What Is the Stock Symbol for AngioLab?

The stock symbol for AngioLab is "251280."

What Is the AngioLab Market Cap?

As of today, AngioLab market cap is 13.39B.

What Is AngioLab's Earnings Per Share (TTM)?

The AngioLab EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is 251280 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has AngioLab Stock Split?

AngioLab has split 0 times.

How Many Employees Does AngioLab Have?

AngioLab has 0 employees.

What is the current trading status of AngioLab (251280)?

As of 09 Aug 2025, AngioLab (251280) is trading at a price of 4,080.00, with a previous close of 4,095.00. The stock has fluctuated within a day range of 4,000.00 to 4,100.00, while its 52-week range spans from 3,715.00 to 9,200.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.